Physician profile
Isabel Otero
NPI 1447860010
$943.36
in general payments reported to CMS, 2019-2025
12 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.96 · 2022: $130 · 2023: $297 · 2024: $306 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $214.46 | 2022-2024 | Airsupra, Farxiga |
| Novo Nordisk INC | $204.15 | 2023-2025 | Ozempic, Rybelsus |
| Daiichi Sankyo INC. | $151.72 | 2022-2023 | Injectafer |
| Idorsia Pharmaceuticals US INC | $78.07 | 2022-2023 | Quviviq |
| Glaxosmithkline, LLC. | $76.67 | 2023-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Exact Sciences Corporation | $59.37 | 2023-2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.83 | 2025 | Xifaxan |
| Otsuka America Pharmaceutical, INC. | $27.90 | 2023 | Rexulti |
| Lilly USA, LLC | $21.70 | 2022 | |
| Sanofi Pasteur INC. | $21.53 | 2023 | |
| Abbvie INC. | $20.25 | 2021 | |
| Esperion Therapeutics, INC. | $13.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isabel Otero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.